Blog Full Right Sidebar

With Frame
Auto ancillary stocks have significantly outperformed OEMs in 2025, with several companies delivering over 100% returns. Projections indicate India’s auto component market could reach $200 billion by 2030, fueled by strong export growth and the nation’s role as a global manufacturing hub. Lumax Auto Technologies led the pack with a 131% surge.
Read More
India’s economy and markets displayed remarkable antifragility in 2025, not just enduring shocks but strengthening from them. Domestic investors stepped in decisively as global uncertainty and trade tariffs briefly unsettled markets. The India-UK FTA and a robust IPO market highlight India’s growing global role and investor confidence, with participation expanding beyond major cities.
Read More
Gujarat Kidney and Super Speciality debuted on stock exchanges with a 6% premium, opening at Rs 120.75 on BSE and Rs 120 on NSE, against its IPO price of Rs 114. The Rs 251 crore IPO saw healthy investor participation, driven by strong retail demand, despite muted grey market signals.
Read More
After aggressive rate cuts in 2025, the US Federal Reserve faces a deep internal divide over whether to ease further or hold policy tight amid cooling inflation and labour market uncertainty.
Read More
Indian stock markets are undergoing a healthy consolidation phase. This period is expected to create reasonable valuations for the next 12 to 15 months. Earnings are projected to accelerate in the coming years. Largecap stocks are anchoring portfolios amid market volatility. Domestic-facing sectors are favored, while IT services are viewed with caution due to AI disruption.
Read More
1 1,841 1,842 1,843 1,844 1,845 3,635

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Recent News

Tata Technologies Q4 Results: Cons PAT rises 8% YoY to Rs 204 crore, revenue rises 22%
May 4, 2026
CSB Bank Q4 profit rises 6% on lower provisions, growth steady
May 4, 2026
Tata Chemicals Q4 results: Cons loss widens YoY to Rs 2,132 crore on exceptional items; revenue drops 2%
May 4, 2026

Recent Cases